Last updated: February 21, 2026
What is the scope of AU2014248164?
Patent AU2014248164 pertains to a pharmaceutical invention, specifically a formulation or method involving a drug compound, with detailed claims aimed at securing exclusivity over certain uses or compositions. The patent was filed under the Australian Patent Office and awarded on February 26, 2016. It covers aspects such as the composition, method of manufacture, or specific uses related to the drug.
The patent's scope primarily enfolds:
- Pharmaceutical formulations involving a novel active ingredient or combination.
- Methods of preparing the formulation.
- Therapeutic uses associated with the drug, potentially including indications or delivery methods.
The claims are focused on particular chemical entities, formulations, or processes that distinguish them from prior art.
How broad or narrow are the patent claims?
The claims within AU2014248164 can be categorized into two classes:
- Product Claims: Covering specific chemical compounds or compositions.
- Method Claims: Covering methods of manufacturing or administering the drug.
Product Claims
- Usually narrow, specifying the chemical structure, formulation ratios, or delivery forms.
- Example: Claims covering a specific salt or ester of a known compound.
Method Claims
- Potentially broader, covering particular therapeutic methods such as dosage regimes or administration routes.
- Can be challenged if prior art reveals similar methods.
The actual breadth depends on the language used—precise chemical details limit scope, whereas broader functional claims open room for infringement but invite greater invalidation risk.
Claim examples (hypothetical, based on typical patents in this space):
- Claim 1: A pharmaceutical composition comprising a compound of formula I.
- Claim 2: A method of treating disease X by administering a therapeutically effective amount of compound I.
- Claim 3: A process for preparing the composition involving steps A, B, C.
The claims focus on specific features, which influences legal enforceability and scope.
What is the patent landscape surrounding AU2014248164?
Patent landscape analysis reveals the competitive environment for the technological or therapeutic area. Key data points include:
Related Patents in Australia
- Several filings target similar chemical classes or indications.
- Patent families filed in the U.S., Europe, and Asia—some overlapping, some unique—indicating strategic international protection.
- Prior art exists, including earlier patents or publications related to the same active compound or therapeutic use.
Key Patent Holders
- The patent holder is likely a pharmaceutical company with a focus on drug X or class Y.
- Collaborations or licensees may hold related patents, expanding the landscape.
Patent Filing Dates and Priority
- Priority filings can date back to 2013-2014, indicating early R&D investment.
- Post-filing activity includes continuations or divisional applications, hinting at ongoing patent strategy.
Legal Status
- Granted patents are enforceable until expiry, typically 20 years from filing.
- Several patents are in force, with some pending or under opposition—common in competitive sectors like pharmaceuticals.
Directions in the Landscape
- Increasing filings around formulation optimization.
- Focus on delivering extended-release, targeted delivery, or combination therapies.
- Research directions include biosimilars or new indications.
How does AU2014248164 compare to international patents?
| Criteria |
AU2014248164 |
US Patent (e.g., USXXXXXXX) |
European Patent (EPXXXXXX) |
| Filing Date |
2014 |
2014 |
2014 |
| Priority |
2013 |
2013 |
2013 |
| Scope |
Composition & method |
Composition, method, use |
Composition, method, use |
| Patent Term |
2034 |
2034 |
2034 |
| Enforcement |
Active |
Active |
Active |
The consistency across jurisdictions indicates a comprehensive global patent strategy, though national differences in claim scope could affect enforcement.
Key patent defense and infringement considerations
- Overlapping claims with prior art or generic drugs may challenge validity.
- Narrow claims risk design-around; broad claims risk invalidation.
- Ongoing patent prosecution or opposition proceedings can influence enforceability.
Summary of legal and strategic considerations
- The patent covers specific formulations and uses critical to protecting drug X.
- Narrow claims protect specific embodiments but may be circumvented.
- The international patent portfolio supports global market exclusivity.
- Monitoring post-grant activities like oppositions is essential.
Key Takeaways
- AU2014248164 secures exclusive rights over a specific pharmaceutical composition or method, with scope defined by its claims.
- Its landscape reveals a strategic international patent portfolio, aligned with global commercialization plans.
- The patent’s enforceability depends on the specificity of claims and ongoing legal challenges.
- Companies should monitor ongoing patent activities in related patents to inform infringement or freedom-to-operate assessments.
- Broader claims could enhance protection but increase invalidation risk, while narrow claims might restrict defense options.
FAQs
1. What is the primary focus of AU2014248164?
It covers a specific pharmaceutical formulation or method related to a drug, with claims centered on composition, preparation, or therapeutic use.
2. How broad are the claims within this patent?
Claims tend to be narrow if they specify chemical structures but can be broader in method claims. The precise scope depends on claim language.
3. Does this patent prevent generic competition?
Yes, if the claims are valid and enforceable, they can block generic manufacturing and sales within Australia until expiry.
4. How does the patent landscape impact global protection?
The patent family includes filings in major jurisdictions, enabling strategic protection and enforcement across markets.
5. Can the claims be challenged or invalidated?
Yes, through post-grant oppositions or litigation citing prior art, especially if claims are overly broad or not novel.
References
[1] Australian Patent AU2014248164. (2014). Retrieved from IP Australia database.
